Psychedelic Stocks to Watch in New Year 2021

Psychedelic stocks are becoming just as popular with investors.

According to Bloomberg, “early-stage investors predicting such substances have an even better shot than cannabis at disrupting the $70 billion market for mental health.”  In addition, “Peter Thiel, the Facebook and PayPal investor, and David Bronner, chief executive of Dr. Bronner’s Magic Soaps, both of whom were known names early in marijuana, are two high-profile players in the hot-but-edgy realm of hallucinogenic drugs.”

Plus, we’re already seeing a good deal of clinical studies on psilocybin for example, for the treatment of obsessive-compulsive disorder, PTSD, opioid addiction, alcoholism, eating disorders, depression and anxiety.

In addition, we’re seeing broader support in the U.S. with Oregon, Denver, Oakland, and Santa Cruz legalizing the use of psilocybin.